Polen Capital Management
CLB icon

Polen Capital Management’s Core Laboratories CLB Stock Holding History

Polen Capital Management’s Portfolio CLB Stock Details CLB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		– Sell
-3,094
Closed -$524K – 25
2013
Q3 		$524K Sell
3,094
-212
-6% -$32.9K 0.01% 23
2013
Q2 		$501K Buy
+3,306
New +$468K 0.01% 22

Other funds holding CLB

Brown Advisory
Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return
CG
Carmignac Gestion Paris, France $7.71B AUM 4.02% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return
WI
WHV Investments San Francisco, California $187M AUM 14.29% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
VAM
Vontobel Asset Management New York $18.1B AUM 28.09% 1-Year Est. Return

Polen Capital Management's CLB Position: Q4 2013 in Review

Polen Capital Management sold out of Core Laboratories (CLB) in Q4 2013, closing a stake of 3,094 shares — an estimated $524K sold.

Polen Capital Management first reported a position in CLB in Q2 2013 and held it in 2 quarters. The position peaked at $524K in Q3 2013. 345 funds tracked by Wall St. Rank hold CLB as of Q4 2013.

  • Polen Capital Management reported no remaining Core Laboratories position as of Q4 2013 after selling out during the quarter.
  • Polen Capital Management sold 3,094 Core Laboratories shares in Q4 2013, an estimated $524K.
  • Polen Capital Management first reported a position in Core Laboratories in Q2 2013 and held it in 2 quarters.
  • Polen Capital Management's Core Laboratories position peaked at $524K in Q3 2013.
  • 345 funds tracked by Wall St. Rank held Core Laboratories as of Q4 2013.

Based on Polen Capital Management's 13F filing for Q4 2013, filed 13 Feb 2014.